Document Detail

Effect of low-density lipoprotein apheresis on lipoprotein-associated phospholipase A2.
MedLine Citation:
PMID:  15878003     Owner:  NLM     Status:  MEDLINE    
Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) is a proinflammatory participant in atherosclerosis and a potential biomarker for coronary heart disease. The effects of low-density lipoprotein (LDL) apheresis on Lp-PLA(2) levels were evaluated in 8 patients with cardiovascular disease. Each patient received 5 LDL apheresis treatments over a 3-month period. The mean direct LDL cholesterol level reduction was 60% (252 to 100 mg/dl). LDL apheresis acutely reduced Lp-PLA(2) by 21.4%. Over the course of treatment, Lp-PLA(2) levels were reduced by 29%. Chronic LDL apheresis significantly reduces Lp-PLA(2) independent of LDL cholesterol, which may be a potential mechanism by which LDL apheresis diminishes coronary heart disease risk.
Patrick M Moriarty; Cheryl A Gibson
Related Documents :
7296813 - Signification of high density and total cholesterol and triglycerides in acute myocardi...
10938023 - Associations of coronary heart disease risk factors with the intermediate lesion of ath...
3875433 - Intermediate-term results of coronary artery bypass grafting for acute myocardial infar...
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  The American journal of cardiology     Volume:  95     ISSN:  0002-9149     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  2005 May 
Date Detail:
Created Date:  2005-05-09     Completed Date:  2005-06-23     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1246-7     Citation Subset:  AIM; IM    
Department of Internal Medicine, University of Kansas School of Medicine, Kansas City, Kansas 66160, USA. <>
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
1-Alkyl-2-acetylglycerophosphocholine Esterase
Blood Component Removal*
Cardiovascular Diseases / blood,  therapy*
Cholesterol, LDL / blood*
Hyperlipoproteinemia Type II / blood,  therapy*
Middle Aged
Phospholipases A / blood*
Phospholipases A2
Treatment Outcome
Reg. No./Substance:
0/Cholesterol, LDL; EC 3.1.1.-/Phospholipases A; EC A2; EC Esterase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Meta-analysis of survival and relief of angina pectoris after transmyocardial revascularization.
Next Document:  Influence of the randomized trials, AFFIRM and RACE, on the management of atrial fibrillation in two...